Nextech Invest

Latest statistics and disclosures from Nextech Invest's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RVMD, ORIC, TYRA, CRGX, ARVN, and represent 72.81% of Nextech Invest's stock portfolio.
  • Added to shares of these 5 stocks: TYRA (+$25M), RLAY (+$21M), SLN (+$21M), Boundless Bio (+$18M), ORIC (+$14M).
  • Started 2 new stock positions in SLN, Boundless Bio.
  • Reduced shares in these 3 stocks: Ambrx Biopharma (-$45M), ARVN (-$12M), MRSN (-$9.5M).
  • Sold out of its position in Ambrx Biopharma.
  • Nextech Invest was a net buyer of stock by $32M.
  • Nextech Invest has $631M in assets under management (AUM), dropping by 17.51%.
  • Central Index Key (CIK): 0001911010

Tip: Access up to 7 years of quarterly data

Positions held by Nextech Invest consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Nextech Invest

Nextech Invest holds 12 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Revolution Medicines (RVMD) 32.2 $203M 6.3M 32.23
 View chart
Oric Pharmaceuticals (ORIC) 11.5 $73M +23% 5.3M 13.75
 View chart
Tyra Biosciences (TYRA) 10.5 $67M +61% 4.1M 16.40
 View chart
Cargo Therapeutics (CRGX) 9.4 $59M 2.6M 22.32
 View chart
Arvinas Ord (ARVN) 9.2 $58M -16% 1.4M 41.28
 View chart
Tango Therapeutics (TNGX) 7.0 $44M 5.5M 7.94
 View chart
Relay Therapeutics (RLAY) 5.1 $32M +185% 3.8M 8.30
 View chart
Cullinan Oncology (CGEM) 3.3 $21M 1.2M 17.04
 View chart
Silence Therapeutics Ads (SLN) 3.3 $21M NEW 952k 21.60
 View chart
Silverback Therapeutics (SPRY) 3.1 $20M 1.9M 10.22
 View chart
Boundless Bio 2.8 $18M NEW 1.2M 14.25
 View chart
Mersana Therapeutics (MRSN) 2.7 $17M -35% 3.9M 4.48
 View chart

Past Filings by Nextech Invest

SEC 13F filings are viewable for Nextech Invest going back to 2021